SPS with the support of specialist stakeholders including NICE, RCGP, ARPHAI, PHE and NHSE, have produced the first national PGD template for antimicrobial treatment.
The aim of this template is to produce a consistent presentation which has been reviewed by antimicrobial specialists. The working group has ensured that the legislative and clinical parameters have been fully considered.
This PGD template may require local adaptation to reflect local policies, commissioning arrangements etc – the areas within the PGD template requiring local adaptation are highlighted in blue throughout the template.
The PGD template contains advisory text (highlighted in yellow) intended to support the adoption of the PGD – all text in yellow highlight should be removed from the final version of the PGD.
Each organisation using this PGD template must ensure that it is clinically signed by a senior pharmacist, a senior doctor, a specialist within microbiology, and any other professional group representatives involved in its use and that it is reviewed in line with the organisation’s PGD governance system. The organisation’s governance lead (or nominated deputy) must sign to authorise the PGD on behalf of the authorising organisation to ensure that this document meets legal requirements for a PGD. See SPS website or NICE guidance for further guidance on signatories.
It is intended that this template will be reviewed and re-released prior to reaching its expiry date. If any relevant changes occur to the product SPC or other guidance then an earlier review will be undertaken. Any decision to locally extend a stated expiry date needs to be locally assessed and agreed as per the organisation’s local policy
PGD template for the administration of benzylpenicillin injection
This PGD template has been developed to support the immediate administration of a single dose of benzylpenicillin injection prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia. The template is below.